Wound Healing as Functional Biomarker and Mechanistic Subtyping Tool

1 Background and Rationale

The selective energy dysfunction hypothesis (Chapter:energy-metabolism, Section:selective-energy-dysfunction) previously listed wound healing among preserved autonomous functions. Literature integration (Chapter:energy-metabolism, Section:wound-healing-mecfs) revealed this assumption is unsupported: no study has measured wound healing in ME/CFS, and mechanistic evidence from three independent pathways β€” NK cell dysfunction (cytotoxicity reduced; NK cells regulate wound healing via IFN-Ξ³/GM-CSF; chronic TGF-Ξ² disrupts NK-MSC temporal cycling), sympathetic overactivation, and immune exhaustion β€” each based on single studies with substantial caveats, suggests abnormal healing dynamics rather than normal preservation. This creates a testable question with implications for both the selective dysfunction framework and clinical biomarker development.

2 Study Design

Design: Prospective three-arm case-control. \(n = 40\) ME/CFS patients (ICC criteria) + 20 age/sex-matched sedentary healthy controls + 20 disease controls (fibromyalgia or multiple sclerosis patients matched for disability level and sedentary lifestyle). The disease control arm distinguishes ME/CFS-specific wound healing abnormalities from generic deconditioning- or disability-associated effects. Primary outcome: Suction blister reepithelialization time (standardised 8mm blister, negative pressure method β€” an established dermatological technique, low-risk, bedside-feasible). Secondary outcomes:

  • Histological scar quality at day 14 and day 28 (collagen organisation, inflammatory infiltrate, vascularity)
  • Blister fluid cytokine panel: IFN-Ξ³, GM-CSF (NK cytokine output β€” note: distinct from NK cytotoxicity measured by Baraniuk), TGF-Ξ² (MSC-NK regulatory circuit), catecholamines (local sympathetic drive β€” note: blister fluid catecholamines reflect local wound-site trauma response and may not directly index systemic sympathetic tone; concurrent medications including beta-blockers must be recorded and analysed as covariates)
  • Correlation with NK cell cytotoxicity and NK cytokine secretion (IFN-Ξ³, GM-CSF from stimulated PBMCs β€” both measures needed to test whether cytotoxicity reduction predicts cytokine secretion reduction), HRV (sympathovagal balance), Bell disability score Stratification: Disease severity (mild/moderate/severe), disease duration (less than 3yr, 3–7yr, greater than 7yr), POTS comorbidity (yes/no), beta-blocker use (yes/no).

3 Why This Study Is Uniquely Informative

A single suction blister measurement simultaneously tests: (1) whether wound healing is actually impaired in ME/CFS; (2) which mechanism may dominate (NK vs. ANS vs. immune exhaustion β€” blister fluid cytokines at a single timepoint provide preliminary mechanistic signal, though the four patterns may co-occur or overlap, limiting subtyping resolution without longitudinal sampling or validation against functional assays); (3) whether the selective dysfunction model’s process classification is correct; (4) whether wound healing rate correlates with disease severity (biomarker potential). Because wound healing requires NK cells, autonomic balance, macrophage polarisation, and metabolic capacity, the healing rate is effectively a systems-biology readout β€” a single composite functional biomarker integrating information about multiple dysfunctional systems. This is particularly valuable for severe/bedbound patients where exercise testing (CPET) is impossible.

4 Mechanistic Subtyping Potential

Blister fluid cytokine profiles could distinguish ME/CFS subtypes by dominant repair mechanism:

  • Pattern A (high IFN-Ξ³, low GM-CSF): NK cells shifted to defence mode β€” HIF-1Ξ± pathway active
  • Pattern B (low IFN-Ξ³, low GM-CSF): NK cells globally non-functional β€” general exhaustion
  • Pattern C (high TGF-Ξ²): MSC-NK regulatory circuit constitutively activated
  • Pattern D (high catecholamines): Sympathetic drive to wound macrophages dominates If validated in a prospective cohort, different patterns would suggest different treatment targets to explore in subsequent trials β€” e.g., NK-supportive interventions for Patterns A/B, autonomic modulation for Pattern D, anti-fibrotic approaches for Pattern C. Pattern classification criteria must be pre-registered before unblinding cytokine data to avoid post-hoc subtyping.

5 Feasibility

Estimated cost: ~€500 per participant for the wound procedure, histology, and blister fluid cytokine panel; NK cell cytotoxicity assays (~€150), NK cytokine secretion assays (~€100), and HRV measurement (~€50) add approximately €300 per participant, for a total of ~€800/participant (~€64,000 for 80 participants across three arms). Requires no specialist equipment beyond a suction chamber. Can be performed at bedside (critical for severe patients). Study duration: 6 months recruitment + 1 month follow-up. Single-site feasible.